Table 1.
Study | Total N |
G-allele- freq |
Case G- allele- freq |
Control G- allele- freq |
proport- male |
age min |
age_q1 | age_med | age_q3 | age_max |
---|---|---|---|---|---|---|---|---|---|---|
BG a | 3999 | 0.14 | 0.13 | 0.17 | 0.83 | 18 | 25 | 28 | 30 | 58 |
CADD b | 409 | 0.13 | 0.12 | 0.18 | 0.56 | 12 | 21 | 28 | 47 | 72 |
CATS c | 1748 | 0.12 | 0.12 | 0.13 | 0.57 | 18 | 29 | 36 | 43 | 65 |
CEDAR-SADS d | 747 | 0.12 | 0.12 | 0.12 | 0.35 | 14 | 18 | 37 | 42 | 65 |
Cinciripini e | 627 | 0.11 | 0.09 | 0.15 | 0.48 | 18 | 33 | 42 | 50 | 74 |
COGA f | 1024 | 0.12 | 0.11 | 0.13 | 0.46 | 18 | 36 | 43 | 51 | 77 |
COGEND g | 2024 | 0.13 | 0.13 | 0.15 | 0.61 | 25 | 32 | 37 | 41 | 65 |
Finnish Health 2000 h | 1025 | 0.21 | 0.20 | 0.22 | 0.8 | 30 | 37 | 46 | 54 | 87 |
FSCD i | 558 | 0.13 | 0.13 | 0.10 | 0.5 | 18 | 25 | 34 | 40 | 54 |
FT12 j | 617 | 0.22 | 0.48 | 20 | 22 | 22 | 23 | 27 | ||
GADD k | 281 | 0.12 | 0.13 | 0.15 | 0.57 | 12 | 15 | 16 | 19 | 61 |
GESGA l | 3501 | 0.12 | 0.11 | 0.11 | 0.65 | 18 | 39 | 47 | 56 | 84 |
Kreek m | 750 | 0.11 | 0.10 | 0.13 | 0.59 | 17 | 31 | 43 | 52 | 82 |
MCTFR-Parents n | 3842 | 0.11 | 0.10 | 0.11 | 0.46 | 30 | 43 | 46 | 50 | 72 |
NAG-AUS o | 1281 | 0.12 | 0.12 | 0.12 | 0.59 | 18 | 36 | 43 | 50 | 82 |
NAG-FIN p | 879 | 0.21 | 0.7 | 42 | 52 | 55 | 58 | 77 | ||
NYS q | 552 | 0.1 | 0.07 | 0.10 | 0.49 | 35 | 37 | 39 | 41 | 44 |
OYSUP r | 357 | 0.13 | 0.5 | 20 | 21 | 21 | 21 | 23 | ||
PAGES s | 409 | 0.11 | 0.68 | 17 | 27 | 37 | 45 | 68 | ||
PiP t | 809 | 0.11 | 0.11 | 0.15 | 0.48 | 18 | 35 | 43 | 53 | 79 |
ROMA u | 732 | 0.21 | 0.16 | 0.38 | 0.83 | 18 | 25 | 28 | 32 | 53 |
SMOFAM v | 166 | 0.12 | 0.18 | 0.12 | 0.63 | 26 | 27 | 29 | 30 | 62 |
Utah w | 463 | 0.13 | 0.12 | 0.14 | 0.59 | 25 | 54 | 61 | 67 | 86 |
VA-Twin x | 672 | 0.12 | 0.15 | 0.10 | 0.32 | 21 | 30 | 38 | 46 | 58 |
Yale-Penn y | 1217 | 0.12 | 0.41 | 16 | 30 | 39 | 46 | 72 | ||
Total | 28689 | (0.10–0.22) | (0.32–0.83) | (12–42) | (15–54) | (16–61) | (19–67) | (23–87) |